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Abstract
Background: Cytomegalovirus is the most common cause of congenital infection in the developed countries.
Gastrointestinal involvement has been extensively described in both adult and paediatric immunocompromised
patients but it is infrequent in congenital or perinatal CMV infection.
Case presentation: We report on a case of coexistent congenital Cytomegalovirus infection with intestinal
malrotation and positive intestinal Cytomegalovirus biopsy. At birth the neonate showed clinical and radiological
evidence of intestinal obstruction. Meconium passed only after evacuative nursing procedures; stooling pattern was
irregular; gastric residuals were bile-stained. Laparatomy revealed a complete intestinal malrotation and contextually
gastrointestinal biopsy samples of the appendix confirmed the diagnosis of CMV gastrointestinal disease.
Intravenous ganciclovir was initiated for 2 weeks, followed by oral valgancyclovir for 6 month.
Conclusion: CMV-induced proinflammatory process may be responsible of the interruption of the normal
development of the gut or could in turn lead to a disruption in the normal development of the gut potentiating
the mechanism causing malrotation. We suggest the hypothesis that an inflammatory process induced by CMV
congenital infection may be responsible, in the early gestation, of the intestinal end-organ disease, as the intestinal
malrotation. CMV infection should always be excluded in full-term infants presenting with colonic stricture or
malrotation.
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Background
Cytomegalovirus (CMV) is the most common cause of
congenital infection in the developed countries, affecting
0.1–2% of live born infants. The majority of children with
congenital CMV infection (approximately 85%–90%) do
not have clinical findings at birth [1].
Both maternal primary and recurrent infection during
pregnancy can result in congenital infection of the infant.
It has been thought that children born to mothers with
primary CMV infection during pregnancy are much more
likely to have symptoms at birth and suffer sequelae than
those born congenitally infected from a maternal recur-
rent CMV infection [1, 2]. More recent data have shown
the severity of newborn disease do not differ between
primary and non primary infection groups [3].
The most commonly observed physical findings are
petechial rash, jaundice and hepatosplenomegaly with
neurologic abnormalities such as microcephaly and
lethargy. Ophthalmologic examination reveals chorioreti-
nitis and/or optic atrophy in approximately 10% of symp-
tomatic infants and sensorineural hearing loss is detected
in more than two-thirds of symptomatic newborns [1].
Gastrointestinal involvement due to CMV infection has
been extensively described in both adult and paediatric
immunocompromised patients and transplant recipient
but it is rare in immunocompetent adult. The entire GI
tract may be involved, with the esophagus and colon being
the most common sites. The clinical spectrum ranges
from relatively minor symptoms such as diarrhea, mouth
ulcers, esophagitis and malabsorption to more serious
symptoms such as hemorrhage, obstruction and perfor-
ation. [4–6]. However, CMV in association with ulcerative
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Gastrointestinal involvement in congenital or perinatal
CMV infection is infrequent [8, 9].
We report, for the first time, on a case of coexistent
congenital CMV infection with intestinal malrotation
and positive intestinal CMV biopsy.
Case presentation
A male neonate was born by vaginal delivery at 39+3
weeks of gestation to a 30-year-old gravida 2 and para 2
mother. The newborn had a birth weight of 3260 g (30th
percentile), a length of 51 cm (59th percentile) and a
head circumference of 34 cm (25th percentile). Apgar
scores were 9 and 10 at 1 and 5 min, respectively. Clinical
examination at birth was normal, abdomen was palp-
able and the rectum was permeable. Mother’s prenatal
routine TORCH serology screens were negative for
HIV, hepatitis B and C, VDRL/TPHA; negative IgM
antibodies and positive IgG antibodies for Rubella,
Toxoplasma and CMV were detected in the first
trimester. Further investigations up to 34 weeks
revealed a reactivation for CMV (both positive IgG
and IgM antibodies) with a high CMV IgG avidity,
speaking for a maternal secondary CMV infection.
Prenatal ultrasound scannings at 34 and 37 weeks of
gestation revealed dilatation of the small intestine. A
fetal echocardiography at 21st week gestation showed a
structurally normal heart.
At birth the neonate showed clinical and radiological
evidence of intestinal obstruction: meconium passed
only after evacuative nursing procedures; stooling pat-
tern was irregular; gastric residuals were bile-stained;
radiological bowel gas pattern and barium enema were
consistent with intestinal obstruction. The blood investi-
gations revealed mildly raised C-reactive protein levels
(1,2 mg/dL; normal value <0,5). Haemoglobin, white cell
count, platelets, liver enzymes were within normal limits.
Blood and urine cultures for bacteria were negative.
Urine was screened for cytomegalovirus on day one con-
firming congenital CMV infection (>2.700.000 copies/ml).
CMV DNA was detected (6343 copies/ml) by Polymerase
Chain Reaction (PCR) in blood sample on day ten. Patient
was managed with nasogastric decompression; enteral
feeding was discontinued. Laparatomy performed on day
10 revealed a complete intestinal malrotation and context-
ually gastrointestinal biopsy samples of the appendix
confirmed the diagnosis of CMV gastrointestinal disease.
Actually, PCR on tissue samples revealed 1096 CMV-
genome copies/mg. Postoperative management was regu-
lar and the neonate made a good recovery. Serial abdomen
and head ultrasound examination showed no evidence of
hepatosplenomegaly or ventriculomegaly, except for
echogenic periventricular foci next to the third ventricle
consistent with calcification.
Intravenous ganciclovir was initiated on day 17 at a dose
of 6 mg/kg twice daily for 2 weeks, followed by oral val-
gancyclovir at a dose of 16 mg/kg twice daily for 6 month.
Follow-up included fortnightly viral load, liver
enzymes, creatinine and blood urea nitrogen monitoring.
Urine viral load fell from >27 million copies/ml on day
one to 121,000 copies/ml on day 37. Blood viral load
was 6343 copies per millilitre on day 10, and, after
22 days of antiviral therapy, was no more detected.
Serology for CMV showed positive IgG and negative
IgM antibodies. Biochemistry was normal. No adverse
effects from the treatment were seen and the baby
remained asymptomatic. Neurological status remained
normal. Serial ophthalmologic examination ruled out
CMV chorioretinitis. Magnetic resonance imaging (MRI)
at 8 weeks of age showed thinned corpus callosum and
enlarged cisterna magna. Visual and hearing screenings
with evocative visual potentials and otoacustic emissions
were negative. At 2 month the infant showed good thriv-
ing, weighing 4800 g and with a head circumference of
37 cm. Neurologic examination was normal for age.
Discussion
Malrotation is the generic term used to describe the
consequences of an arrest of embryologic development
of the midgut that can occur at any phase of pregnancy
with variable consequences. Rotational anomalies, which
may or may not be symptomatic, are estimated to occur
in between 1 in 200 and 1 in 500 live births. Symptom-
atic malrotation is estimated to occur in 1 in 6000 live
births. From the pathogenetic point of view the anatom-
ical development of the intestinal tract is a complex
process. Simply defined, malrotation is a failure during
development of normal rotation of any part of the
embryonic gut [10].
The classic presentation of malrotation with volvulus
is thus that of a neonate with bilious vomiting. In our
patient findings suggestive of bowel obstruction have
been noted on prenatal sonography and clinical and
radiological evidence of intestinal obstruction were
present at birth. The majority of children with malrota-
tion do not have any predisposing syndrome or genetic
susceptibility. In our patient the intestinal malrotation
was associated with congenital CMV infection and
positive intestinal CMV biopsy. We think that in our
case congenital CMV infection may be etiologically
associated with rotational anomalies.
It is not clear the exact role of the CMV infection in
the pathogenesis of intestinal malrotation.
CMV-induced proinflammatory process may be
responsible of the interruption of the normal develop-
ment of the gut or could in turn lead to a disruption in
the normal development of the gut potentiating the
mechanism causing malrotation.
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On the other hands other authors described CMV as a
viral agent that may be involved in surgical pathology in
neonates [11]. To confirm the causal relationship
between CMV and these pathologic findings, a large-
scale longitudinal prospective screening of CMV in neo-
nates with intestinal conditions should be performed.
Conclusion
We suggest the hypothesis that an inflammatory process
induced by CMV congenital infection may be respon-
sible, in the early gestation, of the intestinal end-organ
disease, as the intestinal malrotation. CMV infection
should always be excluded in full-term infants present-
ing with colonic stricture or malrotation.
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